The Valley Desk

NCT05384587 · Interventional trial

Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia

Overall registry status Active not recruiting

Phase 2

Conditions Chronic Myelogenous Leukemia - Chronic Phase

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov